US 11661455
Chimeric protein comprising an interferon alpha 2mutant and a PD-L1 binding moiety
granted A61KA61K2039/505A61P
Quick answer
US patent 11661455 (Chimeric protein comprising an interferon alpha 2mutant and a PD-L1 binding moiety) held by Orionis Biosciences, Inc expires Mon May 25 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Orionis Biosciences, Inc
- Grant date
- Tue May 30 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 25 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K2039/505, A61P, A61P35/00